Pages that link to "Q42201490"
Jump to navigation
Jump to search
The following pages link to Clinical and pharmacokinetic evidence of a life-threatening interaction between methotrexate and ketoprofen (Q42201490):
Displaying 50 items.
- (Q24235194) (← links)
- Three cases of malignant neoplasm, pneumonitis, and pancytopenia during treatment with low-dose methotrexate (Q28317554) (← links)
- Clinical use of thymidine as a rescue agent from methotrexate toxicity (Q28326722) (← links)
- Severe renal toxicity due to intermediate-dose methotrexate (Q28342762) (← links)
- Suspected methotrexate toxicity from omeprazole: a case review of carboxypeptidase G2 use in a methotrexate-experienced patient with methotrexate toxicity and a review of the literature (Q33401038) (← links)
- A phase I clinical study of the antipurine antifolate lometrexol (DDATHF) given with oral folic acid. (Q33497955) (← links)
- Non-infectious chemotherapy-associated acute toxicities during childhood acute lymphoblastic leukemia therapy. (Q33557148) (← links)
- Pneumocystis carinii pneumonia complicating low dose methotrexate treatment for psoriatic arthropathy (Q33561536) (← links)
- Methotrexate area under the curve is an important outcome predictor in patients with primary CNS lymphoma: A pharmacokinetic-pharmacodynamic analysis from the IELSG no. 20 trial. (Q33723702) (← links)
- Over-the-counter analgesics and antipyretics: a critical assessment (Q33906949) (← links)
- Flavonoids are inhibitors of human organic anion transporter 1 (OAT1)-mediated transport (Q34125070) (← links)
- Influence of methotrexate exposure on outcome in patients treated with MBVP chemotherapy for primary central nervous system lymphoma (Q34174899) (← links)
- Ketoprofen: a review of its pharmacologic and clinical properties (Q34182286) (← links)
- Methotrexate disposition following concomitant administration of ketoprofen, piroxicam and flurbiprofen in patients with rheumatoid arthritis (Q34346674) (← links)
- Methotrexate and nonsteroidal antiinflammatory drug interactions (Q34552688) (← links)
- Pharmacokinetic-pharmacodynamic drug interactions with nonsteroidal anti-inflammatory drugs (Q34723818) (← links)
- Assessment of the role of renal organic anion transporters in drug-induced nephrotoxicity (Q35155913) (← links)
- Pharmacology of Anticancer Drugs in the Elderly Population (Q35579412) (← links)
- Determinants of the elimination of methotrexate and 7-hydroxy-methotrexate following high-dose infusional therapy to cancer patients. (Q35827596) (← links)
- Biochemical and pharmacological consequences of the interaction between methotrexate and ketoprofen in the rabbit (Q35982202) (← links)
- Non-steroidal anti-inflammatory drugs induce severe hematologic toxicities in lung cancer patients receiving pemetrexed plus carboplatin: A retrospective cohort study (Q36269700) (← links)
- Drug interactions in the oncology patient (Q36279299) (← links)
- Drug-drug interactions involving membrane transporters in the human kidney (Q36543091) (← links)
- Drug interactions important for periodontal therapy (Q36809156) (← links)
- The Problems and Pitfalls of NSAID Therapy in the Elderly (Part II)1 (Q36972832) (← links)
- Co-administration of proton pump inhibitors delays elimination of plasma methotrexate in high-dose methotrexate therapy. (Q37156268) (← links)
- Clinical pharmacokinetics of drugs used in juvenile arthritis (Q37290781) (← links)
- Clinically significant drug-drug interactions between oral anticancer agents and nonanticancer agents: profiling and comparison of two drug compendia. (Q37334707) (← links)
- Symmetric dimethyl arginine and N-acetyl-β-D-glucosaminidase lysozimuria of proximal renal tubules as a target for nephrotoxicity in patients with rheumatoid arthritis treated with disease modifying antirheumatic drugs (Q37455123) (← links)
- Drug transport by breast cancer resistance protein. (Q37793056) (← links)
- Methotrexate--the rapidly acting drug (Q37799085) (← links)
- In Vitro and In Vivo Evidence of the Importance of Organic Anion Transporters (OATs) in Drug Therapy (Q37811961) (← links)
- Pharmacokinetic drug interactions with nonsteroidal anti-inflammatory drugs (Q37944767) (← links)
- Clinical pharmacokinetics of ketoprofen and its enantiomers (Q37950598) (← links)
- Pharmacokinetic drug-drug interactions with methotrexate in oncology (Q37960131) (← links)
- Rational administration schedule for high-dose methotrexate in patients with primary central nervous system lymphoma (Q38005196) (← links)
- Effect of the ATP-binding cassette transporter ABCG2 on pharmacokinetics: experimental findings and clinical implications (Q38071700) (← links)
- Pharmacokinetic drug interactions of commonly used anticancer drugs. (Q38164714) (← links)
- Interactions between anticancer drugs and other clinically used pharmaceuticals. A review (Q38290200) (← links)
- Potential drug interactions associated with glycyrrhizin and glycyrrhetinic acid (Q38397138) (← links)
- Saturable pharmacokinetics in the renal excretion of drugs (Q38618255) (← links)
- Increased Systemic Exposure of Methotrexate by a Polyphenol-Rich Herb via Modulation on Efflux Transporters Multidrug Resistance-Associated Protein 2 and Breast Cancer Resistance Protein (Q38795882) (← links)
- Interaction Between Low-Dose Methotrexate and Nonsteroidal Anti-inflammatory Drugs, Penicillins, and Proton Pump Inhibitors (Q38971860) (← links)
- Interaction of rhubarb and methotrexate in rats: in vivo and ex vivo approaches (Q39063274) (← links)
- Pharmacologic considerations in the treatment of acute lymphoblastic leukemia (Q39522996) (← links)
- Clinical management of cytotoxic drug overdose (Q39536333) (← links)
- Interactions of non-steroidal anti-inflammatory drugs (Q39560487) (← links)
- Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy (Q39642160) (← links)
- Methotrexate in rheumatoid arthritis: an update (Q39746666) (← links)
- Pharmacokinetics of anticancer drugs in children (Q39768346) (← links)